General
Oxford University to launch trial alternating coronavirus vaccines from AstraZeneca and Pfizer-BioNTech
Oxford University says it will launch a trial alternating doses of COVID-19 vaccines created by different manufacturers.
Key points:
- The trial aims to determine whether different COVID-19 doses can be used interchangeably
- If successful, it could lead to a more flexible vaccine rollout, says the UK’s chief health officer
- Britain has been administering vaccines at an interval of 12 weeks to give more people a first dose, unlike other countries
The trial aims to determine whether different COVID-19 vaccine doses — those created by the AstraZeneca and Pfizer-BioNTech pharmaceutical companies — can be used interchangeably.
If successful it could allow greater flexibility in pressured vaccine delivery schedules.
The UK’s Deputy Chief Medical…
-
Noosa News17 hours agoRaising your voice | Noosa Today
-
Noosa News8 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News14 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General16 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why